Targeting CaMKK2 Inhibits Actin Cytoskeletal Assembly to Suppress Cancer Metastasis

CaMKK2 regulates actin cytoskeletal dynamics to promote tumor invasiveness and can be inhibited to suppress metastasis of breast and ovarian cancer, indicating CaMKK2 inhibition as a therapeutic strategy to arrest disease progression.

[1]  A. Lowy,et al.  Macropinocytosis in Cancer-Associated Fibroblasts is Dependent on CaMKK2/ARHGEF2 Signaling and Functions to Support Tumor and Stromal Cell Fitness. , 2021, Cancer discovery.

[2]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[3]  Yu-Feng Su,et al.  MiR-1271 regulates glioblastoma cell proliferation and invasion by directly targeting the CAMKK2 gene , 2020, Neuroscience Letters.

[4]  Sheng Li,et al.  A substitution in cGMP-dependent protein kinase 1 associated with aortic disease induces an active conformation in the absence of cGMP , 2020, The Journal of Biological Chemistry.

[5]  E. Mjolsness,et al.  Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing , 2020, Nature Cell Biology.

[6]  P. Fasching,et al.  Pembrolizumab for Early Triple-Negative Breast Cancer. , 2020, The New England journal of medicine.

[7]  G. Baillie,et al.  Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond , 2019, Nature Reviews Drug Discovery.

[8]  A. Masci,et al.  CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer , 2019, Nature Communications.

[9]  Dong Ik Lee,et al.  PKG-Modified TSC2 Regulates mTORC1 Activity to Counter Adverse Cardiac Stress , 2018, Nature.

[10]  S. Tojkander,et al.  CaMKK2 Regulates Mechanosensitive Assembly of Contractile Actin Stress Fibers. , 2018, Cell reports.

[11]  Melissa Matz,et al.  Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries , 2018, The Lancet.

[12]  Jian-Dong Li,et al.  An update on vinpocetine: New discoveries and clinical implications , 2018, European journal of pharmacology.

[13]  Christian M. Metallo,et al.  The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer. , 2018, Molecular cell.

[14]  Camille L. Rogers,et al.  Sandwiched White Adipose Tissue: A Microphysiological System of Primary Human Adipose Tissue. , 2017, Tissue engineering. Part C, Methods.

[15]  D. Hardie,et al.  Genotoxic Damage Activates the AMPK-α1 Isoform in the Nucleus via Ca2+/CaMKK2 Signaling to Enhance Tumor Cell Survival , 2017, Molecular Cancer Research.

[16]  C. Coarfa,et al.  Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD , 2017, Scientific Reports.

[17]  A. Means,et al.  The Ca2+/Calmodulin/CaMKK2 Axis: Nature's Metabolic CaMshaft , 2016, Trends in Endocrinology & Metabolism.

[18]  K. Rajapakshe,et al.  The camKK2/camKIV relay is an essential regulator of hepatic cancer , 2015, Hepatology.

[19]  Margaret L. Gardel,et al.  Model-based Traction Force Microscopy Reveals Differential Tension in Cellular Actin Bundles , 2015, PLoS Comput. Biol..

[20]  D. Plas,et al.  TRPM3 and miR-204 establish a regulatory circuit that controls oncogenic autophagy in clear cell renal cell carcinoma. , 2014, Cancer cell.

[21]  Anita C. Thomas,et al.  Nitric Oxide Synthase: Non-Canonical Expression Patterns , 2014, Front. Immunol..

[22]  Alexis Gautreau,et al.  Steering cell migration: lamellipodium dynamics and the regulation of directional persistence , 2014, Nature Reviews Molecular Cell Biology.

[23]  L. Racioppi,et al.  Inhibition of Ca2+/Calmodulin–Dependent Protein Kinase Kinase 2 Stimulates Osteoblast Formation and Inhibits Osteoclast Differentiation , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  T. Vallenius,et al.  Assembly of non-contractile dorsal stress fibers requires &agr;-actinin-1 and Rac1 in migrating and spreading cells , 2013, Journal of Cell Science.

[25]  A. Means,et al.  Calcium/Calmodulin-dependent Protein Kinase Kinase 2: Roles in Signaling and Pathophysiology* , 2012, The Journal of Biological Chemistry.

[26]  S. Waldman,et al.  Phosphorylation of vasodilator‐stimulated phosphoprotein Ser239 suppresses filopodia and invadopodia in colon cancer , 2012, International journal of cancer.

[27]  A. Edelman,et al.  A Regulatory Feedback Loop Between Ca2+/Calmodulin-dependent Protein Kinase Kinase 2 (CaMKK2) and the Androgen Receptor in Prostate Cancer Progression* , 2012, The Journal of Biological Chemistry.

[28]  P. Fasching,et al.  Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  D. Chi,et al.  Current surgical management of ovarian cancer. , 2012, Hematology/oncology clinics of North America.

[30]  A. Means,et al.  Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse. , 2012, Molecular endocrinology.

[31]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[32]  A. Means,et al.  The Ca2+/calmodulin-dependent protein kinase kinase, CaMKK2, inhibits preadipocyte differentiation. , 2011, Endocrinology.

[33]  T. Soderling,et al.  Calmodulin-kinases regulate basal and estrogen stimulated medulloblastoma migration via Rac1 , 2011, Journal of Neuro-Oncology.

[34]  X. Chen,et al.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. , 2011, The Journal of clinical investigation.

[35]  A. Ridley.  Life at the Leading Edge , 2011, Cell.

[36]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[37]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[38]  A. Means,et al.  CaM kinase kinase beta-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells. , 2011, Cancer research.

[39]  L. Tecott,et al.  CREB mediates brain serotonin regulation of bone mass through its expression in ventromedial hypothalamic neurons. , 2010, Genes & development.

[40]  T. Renné,et al.  Differential VASP phosphorylation controls remodeling of the actin cytoskeleton , 2009, Journal of Cell Science.

[41]  Jacobus Pfisterer,et al.  Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials , 2009, Cancer.

[42]  Jean-Marc Guinebretière,et al.  A six-gene signature predicting breast cancer lung metastasis. , 2008, Cancer research.

[43]  A. Means,et al.  Hypothalamic CaMKK2 contributes to the regulation of energy balance. , 2008, Cell metabolism.

[44]  K. Hess,et al.  Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  J. Segall,et al.  Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. , 2007, Cancer research.

[46]  J. Kotera,et al.  Overview of PDEs and Their Regulation , 2007, Circulation research.

[47]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[48]  P. Lappalainen,et al.  Stress fibers are generated by two distinct actin assembly mechanisms in motile cells , 2006, The Journal of cell biology.

[49]  S. Lippman,et al.  Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells. , 2005, Cancer research.

[50]  R. Kloner.  Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. , 2004, Circulation.

[51]  T. Soderling,et al.  Calcium Activation of ERK Mediated by Calmodulin Kinase I* , 2004, Journal of Biological Chemistry.

[52]  T. Soderling,et al.  Regulation of Axonal Extension and Growth Cone Motility by Calmodulin-Dependent Protein Kinase I , 2004, The Journal of Neuroscience.

[53]  Marco Peters,et al.  Loss of Ca2+/Calmodulin Kinase Kinase β Affects the Formation of Some, But Not All, Types of Hippocampus-Dependent Long-Term Memory , 2003, The Journal of Neuroscience.

[54]  Weiming Xu,et al.  The role of nitric oxide in cancer , 2002, Cell Research.

[55]  Gary G. Borisy,et al.  Antagonism between Ena/VASP Proteins and Actin Filament Capping Regulates Fibroblast Motility , 2002, Cell.

[56]  U. Walter,et al.  KT5823 Inhibits cGMP-dependent Protein Kinase Activity in Vitro but Not in Intact Human Platelets and Rat Mesangial Cells* , 2000, The Journal of Biological Chemistry.

[57]  S. Illenberger,et al.  Phosphorylation of the Vasodilator-stimulated Phosphoprotein Regulates Its Interaction with Actin* , 2000, The Journal of Biological Chemistry.

[58]  W. Sauerbrei,et al.  Role of isolated locoregional recurrence of breast cancer: results of four prospective studies. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  K. Rottner,et al.  VASP dynamics during lamellipodia protrusion , 1999, Nature Cell Biology.

[60]  U. Walter,et al.  The EVH2 Domain of the Vasodilator-stimulated Phosphoprotein Mediates Tetramerization, F-actin Binding, and Actin Bundle Formation* , 1999, The Journal of Biological Chemistry.

[61]  P. B. Snyder,et al.  Isolation, expression and analysis of splice variants of a human Ca2+/calmodulin-stimulated phosphodiesterase (PDE1A). , 1999, Cellular signalling.

[62]  A. Edelman,et al.  Components of a Calmodulin-dependent Protein Kinase Cascade , 1998, The Journal of Biological Chemistry.

[63]  M. Krieger,et al.  cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. , 1994, The Journal of biological chemistry.

[64]  U. Walter,et al.  Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators. , 1990, The Journal of biological chemistry.

[65]  D. Glass.  Differential responses of cyclic GMP-dependent and cyclic AMP-dependent protein kinases to synthetic peptide inhibitors. , 1983, The Biochemical journal.

[66]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[67]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[68]  H. Ke,et al.  Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds. , 2011, Handbook of experimental pharmacology.

[69]  P Maisonneuve,et al.  Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[70]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[71]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.